[Levosulpiride versus domperidone in the treatment of functional dyspepsia]

Clin Ter. 1994 Feb;144(2):107-14.
[Article in Italian]

Abstract

Levosulpiride, a dopaminergic antagonist was compared in a double-blind randomized study with domperidone for treatment of functional dyspepsia in 50 patients divided into two groups of 25 subjects each. Group I received 25 mg levosulpiride 3 times daily, group II received 10 mg domperidone 3 times daily, all for 30 days. Periodic clinical examination at days 0, 7, 15, 30 showed symptomatic changes. Gallbladder and gastric emptying was studied by ultrasonography at the start and end of treatment. Both drugs had a positive influence on dyspeptic symptoms and on gastric and gallbladder emptying, but the latter parameters were improved significantly more effectively by levosulpiride. As to tolerability, there have been 3 drop-outs and a further 6 patients complained of sides effects that did not require suspension of treatment.

Publication types

  • Clinical Trial
  • Comparative Study
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Benzamides / pharmacology
  • Benzamides / therapeutic use*
  • Domperidone / pharmacology
  • Domperidone / therapeutic use*
  • Dopamine Agents / pharmacology
  • Dopamine Agents / therapeutic use*
  • Double-Blind Method
  • Dyspepsia / drug therapy*
  • Female
  • Gastric Emptying / drug effects
  • Humans
  • Male
  • Middle Aged
  • Pyrrolidines / pharmacology
  • Pyrrolidines / therapeutic use*
  • Sulpiride* / analogs & derivatives*

Substances

  • Benzamides
  • Dopamine Agents
  • Pyrrolidines
  • Domperidone
  • Sulpiride
  • levosulpiride